1)日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧治療ガイドライン2009(JSH2009),ライフサイエンス出版,2009
2)Matchar DB, et al:Systematic review;Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 148:16-29, 2008
3)Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, et al:Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 25:951-958, 2007
4)ONTARGET Investigators, Yusuf S, et al:Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547-1559, 2008
5)Lindholm LH, et al;LIFE Study Group:Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study(LIFE);A randomised trial against atenolol. Lancet 359:1004-1010, 2002
6)Arai T, et al:ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology 64:573-574,2005